MGRX.US Mangoceuticals, Inc. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
0.1603 USD
Close of Nov 16, 2026
0.1495 1.38
Market cap
USD 3.56M
P/E
-
P/B
0.28x
ROE
-75.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MGRX.US undervalued?

Graham number

The Graham number of Mangoceuticals, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mangoceuticals, Inc. Common Stock fundamental analysis

No fundamental analysis for Mangoceuticals, Inc. Common Stock yet.

Mangoceuticals, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mangoceuticals, Inc. Common Stock

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a …

Full company profile